United States · Startup

Cellular Longevity, Inc.

Loyal is a California-based biotechnology firm that researches and develops longevity therapeutics to treat the underlying causes of aging in dogs.

Funding reportedLast round: Series B

San Francisco, United States

What company datasets say Cellular Longevity, Inc. raised

Funding, as reported

Reported in all$115Min dollars
Rounds6
Last roundSeries B
Last round size$45M
Last round dateMar 2024
Investors listed18

Founders and team

From Cellular Longevity, Inc.'s own website: 1 founder, 7 on the team.

Celine HaliouaFounder & CEO
  • Wiwik WatanabeChief Technical Operations Officer
  • Frank AmbrogioVP, Finance and Head of Legal
  • Matt PeloquinVP, Research
  • Phelps PeelerVP, Product and Engineering
  • Blake SchollDirector
  • Kevin ZhangDirector
  • Laura DemingDirector

On 7 portfolio pages

Investors who name them

Each firm lists Cellular Longevity, Inc. on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

The company, in detail

What they build

Built with from their website

Google WorkspaceApple Business ManagerGoogle MeetMicrosoft ExchangeMicrosoft 365 Apps & ServicesVercelAmazon Route 53Zendesk for ServiceAmazon AWSMailchimp Mandrill

+8 more

Microsoft Exchange OnlineZendeskMicrosoft 365AWS CloudOutlookMicrosoft Email ProvidersZendesk Support SuiteGoogle Search Console

Region
California
Revenue
$2.0M a year, as listed
Full record
Every detail in the company directory

Is this your company?

Add your raise, your deck and your story, and put Cellular Longevity, Inc. in front of investors. Or tell us what we have wrong.